$12.51
0[0.00%]
Last update: 4:00PM Get Real Time Here
Latest News for Nevro Stock (NYSE:NVRO)
Nevro Stock (NYSE: NVRO)
Categories: All
Monday, April 15, 2024
Thursday, April 11, 2024
Monday, April 08, 2024
Wednesday, April 03, 2024
Wednesday, February 28, 2024
Thursday, February 22, 2024
Wednesday, February 21, 2024
- Nevro Expects Worldwide Revenue Of $435M-$445M For Full-Year 2024 (Est $444.54M), $97M-$99M For Q1 (Est $98.72M)Benzinga Newsdesk - Feb 21, 2024, 5:15PM
- Nevro Enters Cooperation Agreement With Engaged Capital; Appoints Kirt P. Karros To BoardBenzinga Newsdesk - Feb 21, 2024, 4:58PM
- Nevro Q4 2023 GAAP EPS $(0.25) Beats $(0.49) Estimate, Sales $116.18M Beat $112.48M EstimateBenzinga Newsdesk - Feb 21, 2024, 4:30PM
- Nevro: Q4 Earnings InsightsBenzinga Insights - Feb 21, 2024, 4:30PM
- Earnings Scheduled For February 21, 2024Benzinga Insights - Feb 21, 2024, 5:09AM
Thursday, January 18, 2024
Wednesday, January 17, 2024
Friday, January 12, 2024
Tuesday, January 09, 2024
- Nevro Announces Restructuring, Including Laying Off 63 Employees By End Of Q1 2024Benzinga Newsdesk - Jan 9, 2024, 8:41AM
- Nevro Sees Prelim. FY23 Revenue $425M Vs $418.33M Est.Benzinga Newsdesk - Jan 9, 2024, 8:40AM
- Nevro Sees Prelim. Q4 Revenue $116M Vs $109.26M Est.Benzinga Newsdesk - Jan 9, 2024, 8:39AM
Friday, December 29, 2023
Friday, December 22, 2023
Thursday, December 21, 2023
Friday, December 01, 2023
Thursday, November 30, 2023
Thursday, November 02, 2023
- JP Morgan Maintains Neutral on Nevro, Lowers Price Target to $18Benzinga Newsdesk - Nov 2, 2023, 5:49PM
- What 4 Analyst Ratings Have To Say About NevroBenzinga Insights - Nov 2, 2023, 5:00PM
- Piper Sandler Maintains Underweight on Nevro, Lowers Price Target to $15Benzinga Newsdesk - Nov 2, 2023, 4:17PM
- Truist Securities Maintains Hold on Nevro, Lowers Price Target to $17Benzinga Newsdesk - Nov 2, 2023, 3:59PM
- Morgan Stanley Maintains Equal-Weight on Nevro, Lowers Price Target to $18Benzinga Newsdesk - Nov 2, 2023, 2:47PM
Wednesday, November 01, 2023
Tuesday, October 31, 2023
Thursday, October 05, 2023
Monday, September 18, 2023
Tuesday, August 22, 2023
Monday, August 21, 2023
Thursday, August 17, 2023
Thursday, August 03, 2023
Wednesday, August 02, 2023
- Canaccord Genuity Maintains Buy on Nevro, Lowers Price Target to $57Benzinga Newsdesk - Aug 2, 2023, 3:37PM
- Potential Turnaround Ahead for Nevro: Q2 Earnings, Guidance Lag Wall Street EstimatesVandana Singh - Aug 2, 2023, 2:21PM
- Stocks That Hit 52-Week Lows On WednesdayBenzinga Insights - Aug 2, 2023, 1:55PM
- JP Morgan Maintains Neutral on Nevro, Lowers Price Target to $23Benzinga Newsdesk - Aug 2, 2023, 1:40PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Aug 2, 2023, 1:31PM
- Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Aug 2, 2023, 1:07PM
- RBC Capital Maintains Outperform on Nevro, Lowers Price Target to $33Benzinga Newsdesk - Aug 2, 2023, 12:05PM